Giles Richard Platford sold $1.2M of Takeda Pharmaceutical Company Limited (TAK)

Executed Nov 4, disclosed Nov 5, 1 day later.

Value, as filed

$1.2M

55,617 sh × $20.90

Executed

Nov 4

the trade date, as filed

Disclosed

Nov 5

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Giles Richard Platford President, IBU profile →

Giles Richard Platford (President, IBU) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $1.2M of TAK (55,617 sh × $20.90, as filed), executed Nov 4.

The name

TAK

Takeda Pharmaceutical Company Limited TAK · Healthcare · 21 filings in 24 months ticker →

Healthcare · Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical pro…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Giles Richard Platford in TAK

TAKSALE Takeda Pharmaceutical Company Limited $532K
31,083 sh × $17.10
Exec Aug 10
Filed Aug 12 · 9:25 PM ET